BERTHIAUME DOUGLAS A 4
4 · GENZYME CORP · Filed Apr 6, 2011
Insider Transaction Report
Form 4
GENZYME CORPGENZ
BERTHIAUME DOUGLAS A
Director
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2011-04-04$62.16/sh−15,000$932,400→ 0 totalExercise: $62.16From: 2008-05-24Exp: 2017-05-24→ Genzyme common stock (GENZ) (15,000 underlying) - Disposition from Tender
Genzyme common stock (GENZ)
2011-04-04$74.00/sh−4,048$299,552→ 0 total(indirect: By Spouse) - Disposition to Issuer
Stock Option (right to buy)
2011-04-04$58.66/sh−7,500$439,950→ 0 totalExercise: $58.66From: 2010-05-21Exp: 2019-05-21→ Genzyme common stock (GENZ) (7,500 underlying) - Disposition to Issuer
Stock Option (right to buy)
2011-04-04$58.50/sh−15,000$877,500→ 0 totalExercise: $58.50From: 2007-05-25Exp: 2016-05-26→ Genzyme common stock (GENZ) (15,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2011-04-04$62.98/sh−15,000$944,700→ 0 totalExercise: $62.98From: 2006-05-26Exp: 2015-05-26→ Genzyme common stock (GENZ) (15,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2011-04-04$68.48/sh−7,500$513,600→ 0 totalExercise: $68.48From: 2009-05-22Exp: 2018-05-22→ Genzyme common stock (GENZ) (7,500 underlying)
Footnotes (1)
- [F1]This option, which provided for vesting at the next annual meeting of shareholders, was cancelled upon the consummation of the sanofi-aventis tender offer in exchange for a payment representing (A) an amount of cash equal to the excess of $74.00 over the exercise price of the option, multiplied by the total number of shares subject to such options, and (B) one contingent value right (CVR) per cancelled option.